Bristol-Myers Squibb GmbH & Co. KGaA
- Pharmaceutical Sales 2010
-
Worldwide: 19.5 billion US $
- Product Range
- Cardiovascular Diseases, Neurology (Schizophrenia), , Virology (HIV/AIDS, Hepatitis B), Oncology, Rheumatoid Arthritis, Pain Therapy
- Key Research Areas
- Cardiovascular- and Metabolic Diseases (Atherosklerosis / Thrombosis, Diabetes, Obesity), Neuroscience (Psychiatric Disorders, Alzheimer´s Disease, Dementia), Virology (Hepatitis, HIV/AIDS), Oncology, Immunoscience (Rheumatoid Arthritis and Related Diseases, Solid Organ Transplant Rejection)
- R&D Expenditure 2010
-
Worldwide: 3.6 billion US $
- Employees in the Pharmaceuticals Division 2010
-
not specified
(All data based on corporate information, as of: 05/2011)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page